SIGNIFY HEALTH INC -CLASS A (SGFY)
US82671G1004 - Common Stock
Overall SGFY gets a fundamental rating of 4 out of 10. We evaluated SGFY against 118 industry peers in the Health Care Providers & Services industry. The financial health of SGFY is average, but there are quite some concerns on its profitability. SGFY is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
SGFY had negative earnings in the past year.
In the past year SGFY had a positive cash flow from operations.
SGFY had negative earnings in 4 of the past 5 years.
In the past 5 years SGFY always reported a positive cash flow from operatings.
1.2 Ratios
The profitability ratios for SGFY are negative, so there is not much use analyzing them.
The Return On Invested Capital of SGFY (6.14%) is better than 67.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | 6.14% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
SGFY's Operating Margin of 13.53% is amongst the best of the industry. SGFY outperforms 89.38% of its industry peers.
In the last couple of years the Operating Margin of SGFY has grown nicely.
SGFY has a Gross Margin of 45.33%. This is in the better half of the industry: SGFY outperforms 72.57% of its industry peers.
In the last couple of years the Gross Margin of SGFY has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.53% | ||
| PM (TTM) | N/A | ||
| GM | 45.33% |
OM growth 3Y50.3%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.69%
GM growth 5YN/A
2. Health
2.1 Basic Checks
SGFY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, SGFY has more shares outstanding
Compared to 1 year ago, SGFY has a worse debt to assets ratio.
2.2 Solvency
SGFY has an Altman-Z score of 3.36. This indicates that SGFY is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.36, SGFY is in the better half of the industry, outperforming 76.99% of the companies in the same industry.
The Debt to FCF ratio of SGFY is 93.50, which is on the high side as it means it would take SGFY, 93.50 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 93.50, SGFY is in line with its industry, outperforming 52.21% of the companies in the same industry.
SGFY has a Debt/Equity ratio of 0.53. This is a neutral value indicating SGFY is somewhat dependend on debt financing.
SGFY has a Debt to Equity ratio of 0.53. This is in the better half of the industry: SGFY outperforms 60.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 93.5 | ||
| Altman-Z | 3.36 |
ROIC/WACC0.66
WACC9.37%
2.3 Liquidity
SGFY has a Current Ratio of 1.62. This is a normal value and indicates that SGFY is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of SGFY (1.62) is better than 67.26% of its industry peers.
A Quick Ratio of 1.62 indicates that SGFY should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.62, SGFY is in the better half of the industry, outperforming 72.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.62 | ||
| Quick Ratio | 1.62 |
3. Growth
3.1 Past
The earnings per share for SGFY have decreased strongly by -390.91% in the last year.
Looking at the last year, SGFY shows a very strong growth in Revenue. The Revenue has grown by 23.33%.
The Revenue has been growing by 17.09% on average over the past years. This is quite good.
EPS 1Y (TTM)-390.91%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-253.85%
Revenue 1Y (TTM)23.33%
Revenue growth 3Y17.09%
Revenue growth 5YN/A
Revenue growth Q2Q232.24%
3.2 Future
The Earnings Per Share is expected to grow by 93.52% on average over the next years. This is a very strong growth
SGFY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.33% yearly.
EPS Next Y200.72%
EPS Next 2Y93.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.26%
Revenue Next 2Y15.48%
Revenue Next 3Y18.86%
Revenue Next 5Y18.33%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for SGFY. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 94.60, SGFY can be considered very expensive at the moment.
SGFY's Price/Forward Earnings is on the same level as the industry average.
SGFY's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 20.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 94.6 |
4.2 Price Multiples
SGFY's Enterprise Value to EBITDA ratio is in line with the industry average.
SGFY's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1516.44 | ||
| EV/EBITDA | 32.74 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SGFY's earnings are expected to grow with 93.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y93.52%
EPS Next 3YN/A
5. Dividend
5.1 Amount
SGFY has a Yearly Dividend Yield of 1.26%.
Compared to an average industry Dividend Yield of 2.74, SGFY pays a better dividend. On top of this SGFY pays more dividend than 85.84% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, SGFY's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.26% |
5.2 History
SGFY does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y93.52%
EPS Next 3YN/A
SIGNIFY HEALTH INC -CLASS A
NYSE:SGFY (3/28/2023, 7:04:01 PM)
After market: 30.49 0 (0%)30.49
+0.02 (+0.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap5.46B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.26% |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 94.6 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 13.53% | ||
| PM (TTM) | N/A | ||
| GM | 45.33% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.62 | ||
| Quick Ratio | 1.62 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-390.91%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y200.72%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)23.33%
Revenue growth 3Y17.09%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y